2000 (9) TMI 125 - AT - Central Excise

Summary

Issues involved: Mode of valuation of samples of patent and proprietary medicaments.

Summary:
The Appellate Tribunal CEGAT, Mumbai considered the appeal regarding the valuation of samples of patent and proprietary medicaments manufactured by the respondent. The Collector had accepted the assessee's stance that the valuation should be based on the cost of manufacture, while the department sought valuation based on the value of comparable goods sold by the assessee. The Collector's order lacked reasoning for concluding that prices on physician samples were distinguishable. The Tribunal determined that valuation should be done as per Rule 7 of the Valuation Rules, considering the value of comparable goods sold by the assessee. As the goods in question were not sold, Rule 6(b) did not apply, and the correct valuation method was to base it on comparable goods after necessary adjustments. The Tribunal allowed the appeal, setting aside the impugned order, and directed the Commissioner to allow the respondent to provide details justifying adjustments from the cost of goods sold for proper valuation.

The Tribunal emphasized the application of Rule 7 for valuation, considering the value of comparable goods sold by the assessee, and the need for adjustments in determining the correct valuation of the subject goods. The Commissioner was instructed to review the details provided by the respondent and pass appropriate orders in line with the principles outlined.